MILLBURN, NJ, July 07, 2026 (GLOBE NEWSWIRE) — The next webinar in the 2026 Knock Out Opioid Abuse Day Learning Series will examine the role of prescription drug monitoring in addressing the opioid crisis.
Ipsos annonce la nomination de Claire Charbit au poste de Head of CEO’s Office
Ipsos annonce la nomination
de Claire Charbit au poste
de Head of CEO’s Office
UPDATE Automox MCP Server 2.2 Brings Visual Review, Agentic Patch by Severity Policy Creation, and Live Capability Discovery to Endpoint Operations
New release makes AI-assisted endpoint management more visual, trustworthy, and actionable for IT teams
New release makes AI-assisted endpoint management more visual, trustworthy, and actionable for IT teams
FG Communities Expands in the Raleigh MSA with Three Acquisitions
Acquisitions in Willow Springs, Angier, and Fuquay-Varina deepen FGC’s presence in one of the nation’s fastest-growing markets
Acquisitions in Willow Springs, Angier, and Fuquay-Varina deepen FGC's presence in one of the nation's fastest-growing markets
VINCI: Disclosure of transactions in on shares from June 29th to July 3rd, 2026
Nanterre, July 6th, 2026
Fnac Darty: June 2026 – Half-yearly report on liquidity contract
Ivry-sur Seine – France, July 7, 2026
Fnac Darty : Bilan semestriel du contrat de liquidité Fnac Darty – Juin 2026
Ivry-sur-Seine, le 7 juillet 2026
RNAi Technology Market Size to Reach USD 13.63 Billion by 2035 | SNS Insider
The U.S. RNAi Technology Market is projected to grow from USD 1.24 Billion in 2025 to USD 4.77 Billion by 2035, while the Europe market is expected to expand from USD 0.93 Billion to USD 3.42 Billion, supported by increasing RNA-based therapeutic development and biotechnology investments.
The U.S. RNAi Technology Market is projected to grow from USD 1.24 Billion in 2025 to USD 4.77 Billion by 2035, while the Europe market is expected to expand from USD 0.93 Billion to USD 3.42 Billion, supported by increasing RNA-based therapeutic development and biotechnology investments.
GraniteShares Launches BBUL and PUL, 2x Long ETFs on BlackBerry and Everpure
New single-stock ETFs give investors amplified leveraged daily participation tied to BlackBerry Limited (NYSE: BB) and Everpure, Inc. (NYSE: P)
Lexis+ for Government Becomes the First Legal Research Solution to Achieve FedRAMP® Certified Status
Milestone reflects LexisNexis’s leadership in delivering secure, compliant, cloud-based legal technology to U.S. government agencies
Milestone reflects LexisNexis’s leadership in delivering secure, compliant, cloud-based legal technology to U.S. government agencies
Sompo to Acquire Service Insurance Companies, a Leading Monoline Workers’ Compensation Insurance Company
The acquisition strengthens Sompo’s workers’ compensation franchise with expanded capabilities, distribution reach and scale in the U.S. market
The acquisition strengthens Sompo’s workers’ compensation franchise with expanded capabilities, distribution reach and scale in the U.S. market
Fiat’s Next Move in America: Tiny, Cute, Electric and $14,000
The two-seat Topolino is aimed at traveling in resorts and neighborhoods, and one version uses ropes instead of doors.
Photonic Inc. Names Orlagh Neary Chief Marketing Officer and Briony Shipman Vice President of Global Government Affairs
Former Microsoft Quantum leader and Senior UK Civil Servant join to scale commercialization following the company’s $200M USD raise
Former Microsoft Quantum leader and Senior UK Civil Servant join to scale commercialization following the company’s $200M USD raise
Patra Awarded U.S. Patent for AI Value Extraction
USPTO grant validates the governed, human-in-the-loop AI approach Patra has built since 2022, the same principles that underpin its agentic automation platform.
USPTO grant validates the governed, human-in-the-loop AI approach Patra has built since 2022, the same principles that underpin its agentic automation platform.
BBG Advanced Therapies Launches Mobile Leukapheresis Center, in Collaboration with Kite to Bring CAR T-cell Therapies Closer to Patients
BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, today announced a collaboration with Kite, a Gilead Company and global leader in cell therapy, to deploy BBG Advanced Therapies’ Mobile Leukapheresis Center (MLC) across Texas—marking an important milestone in how patients can access Kite’s CAR T-cell therapies which are individualized cancer treatments made from a patient’s own cells.
BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, today announced a collaboration with Kite, a Gilead Company and global leader in cell therapy, to deploy BBG Advanced Therapies’ Mobile Leukapheresis Center (MLC) across Texas—marking an important milestone in how patients can access Kite’s CAR T-cell therapies which are individualized cancer treatments made from a patient’s own cells.
National Advertising Division Finds Certain Harry’s Plus Razor Claims Supported
In a challenge brought by The Gillette Company, BBB National Programs’ National Advertising Division found that Mammoth Brands, Inc. (Harry’s) provided a reasonable basis for certain claims for its Harry’s Plus razors
In a challenge brought by The Gillette Company, BBB National Programs’ National Advertising Division found that Mammoth Brands, Inc. (Harry’s) provided a reasonable basis for certain claims for its Harry’s Plus razors
OZOP Energy Solutions, Inc. Highlights Launch of Desmond Bane Signature Edition HYDRO Can
WARWICK, NY, July 07, 2026 (GLOBE NEWSWIRE) — OZOP Energy Solutions, Inc. (OTC: OZSC, the “Company”) today highlighted the launch by Ballislife Drink Inc. of its first athlete signature limited edition HYDRO Sports Drink, featuring NBA standout Desmond Bane and an exclusive Piña Colada flavor. Ballislife Drink Inc. is the joint venture between Varon USA, a subsidiary of Varon Corp., and Ballislife, Inc. Ozop and Varon Corp are currently completing customary pre-closing conditions in connection with the previously announced transaction with OZOP.
Privileged Access Management Market Size to Hit $22.93 Billion by 2035 | SNS Insider
The U.S. privileged access management market is expected to reach $6.02 billion by 2035, while Europe is projected to reach $5.01 billion, fueled by rising cyberattacks, GDPR compliance, enterprise cloud adoption, and increasing demand for zero trust and identity-centric security solutions.
The U.S. privileged access management market is expected to reach $6.02 billion by 2035, while Europe is projected to reach $5.01 billion, fueled by rising cyberattacks, GDPR compliance, enterprise cloud adoption, and increasing demand for zero trust and identity-centric security solutions.